Sort
39,280 grants matching “leukemia”
Pharmacogenetics of Nucleobase and Nucleoside Analog Drugs
$574,400Jun J. Yang · St. Jude Children'S Research Hospital · R35 · FY2024 · GM
Resequencing
$574,321Seth Daniel Crosby · Washington University · P01 · FY2012 · CA
A novel approach for treating myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML)
$574,272Xiaomin Fan · Avantgen, Inc. · R44 · FY2025 · CA
AML mutation-guided drugging of DNA repair
$574,264Tomasz Skorski · Temple Univ Of The Commonwealth · R01 · FY2021 · CA
Transfer: DNA Methylation Canyons in Human Cancers: Methods, Target Genes and Functional Consequences
$574,202Wei Li · University Of California-Irvine · R01 · FY2020 · CA
Biologic and Therapeutic Significance of miR-155 in AML
$574,050Guido Marcucci · Beckman Research Institute/City Of Hope · R01 · FY2016 · CA
Hematopathology Fellowship
$574,046Elaine Jaffe · Division Of Basic Sciences - Nci · ZIE · FY2011 · CA
CORE II - Genetics & Informatics Using Statistics CORE (GENIUS)
$574,046Nancy J. Cox · University Of Chicago · U01 · FY2014 · GM
Hematopathology Diagnosis
$574,046Elaine Jaffe · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
UNDERSTANDING AND TARGETING PROTEIN SYNTHESIS IN LEUKEMIA STEM CELLS
$573,999The University Of Texas Southwestern Medical Center · · FY2022 · Department of the Army
Single Cell Methods for Bioeffector Discovery and Analysis
$573,883Brian O Bachmann · Vanderbilt University · R01 · FY2020 · CA
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts
$573,821Sanjay Misra · Mayo Clinic Rochester · R01 · FY2017 · HL
The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia
$573,809Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts
$573,802Sanjay Misra · Mayo Clinic Rochester · R01 · FY2018 · HL
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts
$573,802Sanjay Misra · Mayo Clinic Rochester · R01 · FY2019 · HL
Single-Cell Methods for Analysis of Clonal Heterogeneity and Evolution in Cancer
$573,794Jerald P Radich · Fred Hutchinson Cancer Research Center · R01 · FY2014 · CA
The Role of Hypoxia In Venous Neointimal Hyperplasia In Hemodialysis Grafts
$573,714Sanjay Misra · Mayo Clinic Rochester · R01 · FY2016 · HL
Biomarkers for predicting response to Hsp90 therapy
$573,509Gabriela Chiosis · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA
The role and therapeutic potential of IGF2BP2 in MLL-rearranged leukemia
$573,508Jianjun Chen · Beckman Research Institute/City Of Hope · R01 · FY2022 · CA
The role of inflammation in the regulation of immune response in acute myeloid leukemia
$573,470Iannis Aifantis · New York University School Of Medicine · R01 · FY2025 · CA
An INteractive Survivorship Program to Improve Healthcare REsources [INSPIRE] for Adolescent and Young Adult (AYA) Cancer Survivors
$573,454Kevin S Baker · Fred Hutchinson Cancer Center · U01 · FY2025 · CA
Selection of Allogeneic Hematopoietic Cell Donor Based on KIR and HLA Genotypes
$573,445Katharine C Hsu · Sloan-Kettering Inst Can Research · R01 · FY2017 · HL
Genetic Consequences of Therapies for Cancer
$573,425John Dunning Boice · Vanderbilt University · R01 · FY2009 · CA
Targeting Defective DNA Damage Response Pathways in IDH1/2-mutant AML
$573,404Ranjit Bindra · Yale University · R01 · FY2023 · CA
IMMUNOBIOLOGY OF NORMAL AND NEOPLASTIC LYMPHOCYTES
$573,371Warren S Pear · University Of Pennsylvania · T32 · FY2016 · CA